Till F. Omansen

Mycobacterium ulcerans low infectious dose and mechanical transmission support insect bites and puncturing injuries in the spread of Buruli ulcer

John R. Wallace, Kirstie M. Mangas, Jessica L. Porter et al. · PLoS neglected tropical diseases · 2017 · 115 citations · Full text

Life Sciences, Entomology, Infectious Diseases +14

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial

Richard Odame Phillips, J. Robert, Kabiru Mohamed Abass et al. · The Lancet · 2020 · 110 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Global Epidemiology of Buruli Ulcer, 2010–2017, and Analysis of 2014 WHO Programmatic Targets

Till F. Omansen, Alfred Erbowor-Becksen, Rie Yotsu et al. · Emerging infectious diseases · 2019 · 72 citations · Full text

Public Health, Dermatology, Infectious Diseases +13

In-vitro Activity of Avermectins against Mycobacterium ulcerans

Till F. Omansen, Jessica L. Porter, Paul D. R. Johnson et al. · PLoS neglected tropical diseases · 2015 · 64 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Impact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis

Nicole C. Ammerman, Rosemary V. Swanson, Elaine M. Bautista et al. · Antimicrobial Agents and Chemotherapy · 2018 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16